BiondVax Pharmaceuticals Ltd (NASDAQ:BVXV) CEO Interview

BiondVax Pharmaceuticals Ltd
(NASDAQ: BVXV)
(TASE: BVXV)
President and CEO: Dr. Ron Babecoff

 

THIS INTERVIEW HAS EXPIRED

About The Wall Street Analyzer 1609 Articles
The Wall Street Analyzer's staff of writers, analysts, publishers, producers, market researchers, and PR professionals aim to provide investors with the tools they need to make informed decisions on buying stock. Our staff is a mix of financial professionals and media savvy individuals whose experiences bring the best talent from both ends of the spectrum.

1 Trackback / Pingback

  1. CEO Interview with The Wall Street Analyzer – BiondVax

Comments are closed.